Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum‐pemetrexed for T790M mutation‐positive advanced non–small cell lung cancer
2017 ◽
Vol Volume 10
◽
pp. 1757-1766
◽
2018 ◽
Vol 56
(2)
◽
pp. 179-183
◽